CD44 and ovarian carcinoma: In fact, these authors have shown that primary ovarian cancer specimens were composed of low densities of cells displaying cancer stem cell markers such as ALDH1A1, CD44 and CD133; tumors collected immediately after primary therapy were more densely composed of each of these markers.